The data showed that combining methotrexate and GNPs resulted in pronounced anti-inflammatory effects by reducing the production of IL-6, TNF-a, and IL-1b by monocytes and macrophages and improved RA compared to MTX and GNPs treatments alone [148]. The gene discussed is IL6; the disease is rheumatoid arthritis.